drugset
drugset / Trial / NCT04718636

A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants

NCT04718636 ↗

Phase 1 Completed 28 enrolled Celgene Corporation
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of CC-99677 coadministration on the pharmacokinetics (PK) of an oral contraceptive (OC).

Timeline

Start
2020-09-30
Primary completion
2021-08-03
Completion
2021-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject GAMCEMETINIB Small molecule — —
Subject Ortho Tri-Cyclen Unknown — Oral

Indications

No indication recorded.